Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Tirzepatide (Mounjaro, Zepbound) Tirzepatide targets both GLP-1 and GIP receptors, producing greater average weight loss than semaglutide in head-to-head trials, typically 20 to 25 percent of body weight
Together, they reduce both fasting and postprandial blood sugar levels and support reductions in energy intake
How GLP-1 Medications Work GLP-1 Medications, originally used for diabetes management, function as peptide hormone receptor agonists
2022;119(30):e2119368119
US$ 24.15
US$ 21.68
US$ 25.05
US$ 28.17
